109 related articles for article (PubMed ID: 2685188)
1. The emerging role of 5-fluorouracil and leucovorin in the treatment of advanced breast cancer. A review.
Zaniboni A
J Chemother; 1989 Oct; 1(5):330-7. PubMed ID: 2685188
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil with leucovorin in breast cancer.
Loprinzi CL
Cancer; 1989 Mar; 63(6 Suppl):1045-7. PubMed ID: 2645043
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update.
Marini G; Simoncini E; Zaniboni A; Gorni F; Marpicati P; Zambruni A
Oncology; 1987; 44(6):336-40. PubMed ID: 3500441
[TBL] [Abstract][Full Text] [Related]
4. Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin.
Venturino A; Comandini D; Simoni C; Merlini L; Naso C; Palumbo R; Fusco V; Porcile G; Pronzato P; Rosso R; Repetto L
Breast Cancer Res Treat; 2000 Apr; 60(3):195-200. PubMed ID: 10930106
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
Allegra CJ; Chabner BA; Sholar PW; Bagley C; Drake JC; Lippman ME
NCI Monogr; 1987; (5):199-202. PubMed ID: 3501543
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and well-tolerated regimen for the treatment of advanced breast cancer.
Wils JA
Eur J Cancer; 1993; 29A(15):2106-8. PubMed ID: 8297648
[TBL] [Abstract][Full Text] [Related]
9. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
10. Effective initial therapy of advanced breast cancer with fluorouracil and high-dose, continuous infusion calcium leucovorin.
Margolin KA; Doroshow JH; Akman SA; Leong LA; Morgan RJ; Raschko JW; Somlo G; Blevins C
J Clin Oncol; 1992 Aug; 10(8):1278-83. PubMed ID: 1634917
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
12. Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Stöger H; Bauernhofer T; Kasparek AK; Schmid M; Moser R; Ploner F; Derstvenscheg E; Kuss I; Wilders-Truschnig M; Steindorfer P
Cancer Chemother Pharmacol; 1994; 34(1):75-8. PubMed ID: 8174206
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
14. Modulation of fluoropyrimidines by leucovorin: rationale and status.
Rustum YM
J Surg Oncol Suppl; 1991; 2():116-23. PubMed ID: 1832538
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
[TBL] [Abstract][Full Text] [Related]
16. A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
Ardalan B; Sridhar KS; Benedetto P; Richman S; Waldman S; Morrell L; Feun L; Savaraj N; Fodor M; Livingstone A
Cancer; 1991 Sep; 68(6):1242-6. PubMed ID: 1873776
[TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
[TBL] [Abstract][Full Text] [Related]
18. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G
Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study.
Loprinzi CL; Ingle JN; Schaid DJ; Buckner JC; Edmonson JH; Allegra CJ
Am J Clin Oncol; 1991 Feb; 14(1):30-2. PubMed ID: 1987734
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
